Iron deprivation inhibits cyclin-dependent kinase activity and decreases cyclin D/CDK4 protein levels in asynchronous MDA-MB-453 human breast cancer cells.

被引：0
|
作者：
Kulp, KS
Green, SL
Vulliet, PR
机构：
[1] UNIV CALIF DAVIS,SCH VET MED,DEPT MOL BIOSCI,DAVIS,CA 95616
[2] STANFORD UNIV,DEPT COMPARAT MED,PALO ALTO,CA 94305
来源：
MOLECULAR BIOLOGY OF THE CELL | 1996年 / 7卷
关键词：
D O I：
暂无
中图分类号：
Q2 [细胞生物学];
学科分类号：
071009 ; 090102 ;
摘要：
引用
收藏
页码：2135 / 2135
页数：1
相关论文
共 50 条
  • [31] 1α,25-dihydroxyvitamin D3 induces a drastic change in the phenotype and inhibits the expression of myoepithelial genes in human breast cancer MDA-MB-453 cells
    不详
    ANTICANCER RESEARCH, 2005, 25 (3B) : 2292 - 2293
  • [32] Anti-cancer activity of Psoralea fructus through the downregulation of cyclin D1 and CDK4 in human colorectal cancer cells
    Park, Gwang Hun
    Sung, Ji Ho
    Song, Hun Min
    Jeong, Jin Boo
    BMC COMPLEMENTARY AND ALTERNATIVE MEDICINE, 2016, 16
  • [33] Anti-cancer activity of Psoralea fructus through the downregulation of cyclin D1 and CDK4 in human colorectal cancer cells
    Gwang Hun Park
    Ji Ho Sung
    Hun Min Song
    Jin Boo Jeong
    BMC Complementary and Alternative Medicine, 16
  • [34] UK real-world data (RWD) of cyclin-dependent kinase 4/6 inhibitor (CDK4/6i) use in metastatic breast cancer (MBC)
    Gullick, G.
    Owen, C.
    Cook, S.
    Helbrow, J.
    Squires, R.
    Reed, H. M.
    Park, S.
    Weir, E.
    Aquilina, F.
    Webber, N.
    Nye, E.
    Atkinson, C.
    Blair, C.
    Halstead, A.
    Daniels, E.
    Alves, A.
    Chew, S.
    Thomas, W.
    Spensley, S.
    Robinson, T.
    ANNALS OF ONCOLOGY, 2023, 34 : S360 - S360
  • [35] Anticancer activity of britannin through the downregulation of cyclin D1 and CDK4 in human breast cancer cells (vol 15, pg 1105, 2019)
    Hamzeloo-Moghadam, M.
    Aghaei, M.
    Abdolmohammadi, Mohammad Hossein
    Fallahian, F.
    JOURNAL OF CANCER RESEARCH AND THERAPEUTICS, 2019, 15 (06) : 1424 - 1424
  • [36] Palm oil tocotrienols inhibit protein kinase C activity in MDA-MB-435 human breast cancer cells.
    Guthrie, N
    Gapor, A
    Chambers, AF
    Carroll, KK
    FASEB JOURNAL, 1997, 11 (03): : 3284 - 3284
  • [37] Trilaciclib hydrochloride Cyclin-dependent kinase 4 and 6 (CDK4/6) inhibitor Myelopreservation therapy Treatment of small cell lung cancer Treatment of triple-negative breast cancer
    Barquero, N.
    DRUGS OF THE FUTURE, 2020, 45 (02) : 99 - 107
  • [38] Arcyriaflavin a, a cyclin D1–cyclin-dependent kinase4 inhibitor, induces apoptosis and inhibits proliferation of human endometriotic stromal cells: a potential therapeutic agent in endometriosis
    Tomoko Hirakawa
    Kaei Nasu
    Yoko Aoyagi
    Kanetoshi Takebayashi
    Hisashi Narahara
    Reproductive Biology and Endocrinology, 15
  • [39] Dalpiciclib. Cyclin-dependent kinase 4/6 (CDK4/6) inhibitor, Treatment of HR+/HER2-and HER2+advanced breast cancer
    Wang, Jingru
    Dong, Xiaotong
    Ashby, Charles R.
    Chen, Zhe-Sheng
    Zhang, Yunxiang
    DRUGS OF THE FUTURE, 2022, 47 (12) : 867 - 886
  • [40] HTLV-1 Tax protein interacts with cyclin-dependent kinase inhibitor p16(INK4A) and counteracts its inhibitory activity towards CDK4
    Suzuki, T
    Kitao, S
    Matsushime, H
    Yoshida, M
    EMBO JOURNAL, 1996, 15 (07): : 1607 - 1614
12345